Literature DB >> 8004296

Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness.

D G Peroni1, A L Boner, G Vallone, I Antolini, J O Warner.   

Abstract

We studied the effects of reduced allergen exposure on bronchial hypereactivity (BHR) in two groups of asthmatic children allergic to house dust mites (HDM) living at high altitude for 9 continuous mo. In the first group the serum levels of total and HDM-specific IgE showed significant decreases after 3 mo (p < 0.001 and p < 0.02, respectively) and after 9 mo (p < 0.001). Three months after returning home the total IgE levels had increased significantly (p < 0.001). The mean percentage fall in peak expiratory flow after exercise testing improved after 3 and 9 mo (p < 0.05), but it had deteriorated after 3 mo at home (p < 0.01). The methacholine PD20-FEV1 increased after 3 mo (p = 0.001) and further after 9 mo (p < 0.001), with a decrease after the 3-mo period at sea level (p = 0.01). In the second cohort there was a significant increase in HDM PD20-FEV1 after 6 and 9 mo (p < 0.001), with a slight decrease of magnitude of the allergen-induced late reaction. Histamine PD20-FEV1 significantly increased after 6 and 9 mo at high altitude, particularly in the challenges performed after the HDM bronchial provocation (p < 0.01). Our data demonstrate that allergen avoidance in asthmatic children not only decreases nonspecific BHR but also decreases allergen sensitivity, late allergen-induced bronchial reactions, and enhancement of BHR by allergen challenge.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004296     DOI: 10.1164/ajrccm.149.6.8004296

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

Review 1.  Clinical effects of allergen avoidance.

Authors:  A Custovic; A Woodcock
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

2.  Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study.

Authors:  L H M Rijssenbeek-Nouwens; A J Oosting; M S de Bruin-Weller; I Bregman; J G R de Monchy; D S Postma
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

3.  Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma.

Authors:  E van Velzen; J W van den Bos; J A Benckhuijsen; T van Essel; R de Bruijn; R Aalbers
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

4.  High incidence of exercise-induced bronchoconstriction in triathletes of the Swiss national team.

Authors:  Bruno H Knöpfli; Mona Luke-Zeitoun; Serge P von Duvillard; Adrian Burki; Christian Bachlechner; Heidi Keller
Journal:  Br J Sports Med       Date:  2007-01-19       Impact factor: 13.800

5.  House dust mite allergen avoidance in asthma. Benefits unproved but not yet excluded.

Authors:  D P Strachan
Journal:  BMJ       Date:  1998-10-24

Review 6.  Measurement of airway hyperresponsiveness: new considerations.

Authors:  J Lötvall; M Inman; P O'Byrne
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 7.  Allergen avoidance in the treatment of asthma and atopic disorders.

Authors:  A Custovic; A Simpson; M D Chapman; A Woodcock
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

Review 8.  Discharge of the asthmatic patient.

Authors:  B A Markoff; J F MacMillan; V Kumra
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 9.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 10.  Does climate therapy at moderate altitudes improve pulmonary function in asthma patients? A systematic review.

Authors:  Tanja Massimo; Cornelia Blank; Barbara Strasser; Wolfgang Schobersberger
Journal:  Sleep Breath       Date:  2013-06-18       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.